Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28608516 | 0.89 | CYP2C19 (0.57) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL28606284 | 0.85 | SMN1; SMN2 (0.53) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL5377464 | 0.84 | L3MBTL1 (0.52) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL1458050 | 0.83 | CYP2C19 (1.00) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL1458057 | 0.83 | CYP2C19 (1.00) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL5371218 | 0.83 | CYP2C19 (0.79) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL666893 | 0.83 | CYP2C19 (1.00) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL28608435 | 0.83 | CYP2C19 (0.50) | CYP2C19SMN1; SMN2ALDH1A1HSD17B10ATM | |
| SCHEMBL23457202 | 0.82 | LMNA (0.54) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL1457969 | 0.81 | CYP2C19 (0.96) | CYP2C19LMNASMN1; SMN2ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0642483-B1 | CHLORINATION AND ELIMINATION PROCESS AND SOME PRODUCTS THEREOF | DOW CHEMICAL CO (US) | 1998-02-18 | — | — | EP | claimed |
| US-10106630-B2 | Unsaturated deoxybenzoin compound, polymer prepared therefrom, and articles comprising the polymer | THE UNIVERSITY OF MASSACHUSETTS (US) | 2018-10-23 | — | — | US | disclosed |
| US-10065913-B2 | Unsaturated deoxybenzoin compounds and polymers prepared therefrom | THE UNIVERSITY OF MASSACHUSETTS (US) | 2018-09-04 | — | — | US | disclosed |
| US-20170283355-A1 | UNSATURATED DEOXYBENZOIN COMPOUND, POLYMER PREPARED THEREFROM, AND ARTICLES COMPRISING THE POLYMER | THE UNIVERSITY OF MASSACHUSETTS | 2017-10-05 | — | — | US | disclosed |
| US-20170101361-A1 | UNSATURATED DEOXYBENZOIN COMPOUNDS AND POLYMERS PREPARED THEREFROM | THE UNIVERSITY OF MASSACHUSETTS | 2017-04-13 | — | — | US | disclosed |
| EP-2325693-B1 | Composition for forming a patterned film of surface-modified carbon nanotubes | SAMSUNG ELECTRONICS CO LTD (KR) | 2015-04-08 | — | — | EP | disclosed |
| EP-2325693-A1 | Composition for Forming a Patterned Film of Surface-Modified Carbon Nanotubes | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-05-25 | — | — | EP | disclosed |
| EP-0479593-B1 | Process for acylation or alkylation of aromatic compounds in hydrogen fluoride | HOECHST CELANESE CORP (US) | 1996-06-19 | — | — | EP | disclosed |
| EP-0462776-B1 | Preparation of optically active arylaliphatic carboxylic acids | ALBEMARLE CORP (US) | 1995-12-27 | — | — | EP | disclosed |
| US-5185469-A | Contacting acylating agent and aromatic compound; extracting product into hydrogen fluoride-rich phase | HOECHST CELANESE CORP. (US) | 1993-02-09 | — | — | US | disclosed |
| EP-0479593-A2 | Process for acylation or alkylation of aromatic compounds in hydrogen fluoride | HOECHST CELANESE CORPORATION (US) | 1992-04-08 | — | — | EP | disclosed |
| EP-0462776-A2 | Preparation of optically active arylaliphatic carboxylic acids | ALBEMARLE CORPORATION (US) | 1991-12-27 | — | — | EP | disclosed |
| US-5068448-A | Hydrogen fluoride and an acetylating agent with isobutylbenzene followed by extraction, circulation and withdrawal | HOECHST CELANESE CORPORATION (US) | 1991-11-26 | — | — | US | disclosed |
| EP-0284310-B1 | PROCESS FOR PRODUCING IBUPROFEN | HOECHST CELANESE CORPORATION (US) | 1991-09-11 | — | — | EP | disclosed |
| US-5015764-A | Preparation of optically active aliphatic carboxylic acids | ETHYL CORPORATION (US) | 1991-05-14 | — | — | US | disclosed |
| EP-0284310-A1 | Process for producing ibuprofen | HOECHST CELANESE CORPORATION (US) | 1988-09-28 | — | — | EP | disclosed |
| US-3980698-A | ALPHA-PHENYL-BETA-(LOWER ALKYLPHENYL)ETHYLAMINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10065913-B2 | Unsaturated deoxybenzoin compounds and polymers prepared therefrom | FLAD1, ALKBH1, ALOX15B | CYP2C19 2658/4885LMNA 1173/4885SMN1; SMN2 1890/4885 |
| US-10106630-B2 | Unsaturated deoxybenzoin compound, polymer prepared therefrom, and articles comprising the polymer | RARB, RARA, RARG | CYP2C19 1978/4885LMNA 918/4885SMN1; SMN2 2803/4885 |
| US-20170283355-A1 | UNSATURATED DEOXYBENZOIN COMPOUND, POLYMER PREPARED THEREFROM, AND ARTICLES COMPRISING THE POLYMER | RARB, RARA, RARG | CYP2C19 1978/4885LMNA 918/4885SMN1; SMN2 2803/4885 |
| US-20170101361-A1 | UNSATURATED DEOXYBENZOIN COMPOUNDS AND POLYMERS PREPARED THEREFROM | FLAD1, ALKBH1, ALOX15B | CYP2C19 2658/4885LMNA 1173/4885SMN1; SMN2 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.